10:20 AM EST - Ventripoint Diagnostics Ltd. : Has submitted its next generation of software and hardware, VMS+4.0, for approval under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. Ventripoint Diagnostics Ltd.
shares V.VPT are trading down $0.01 at $0.16.
